AGP Limited (AGP): 4QCY24 expected EPS of PKR 2.86, up 35%YoY - By Taurus Research
Feb 26 2025
Taurus Securities
- 4QCY24: – EPS: PKR 2.86, PAT: ~PKR 849Mn, up ~35% over the SPLY.
- AGP’s topline is expected to arrive-in at ~PKR 7.8Bn for 4QCY24, mainly benefitting from the deregulation of non essential medicines and the Government’s decision of increasing prices of multiple essential medicines. Currently, AGP's revenue mix is evenly split between essential and non-essential medicines on a consolidated basis. Similarly, we expect the gross margin to hover around 54%, aligning with the Company’s historic trend.
- For CY24, sales are expected to clock-in at ~PKR 25Bn, up 36%YoY. However, the upside in revenue is likely to be off-set by increase in expenses, finance cost and taxation, up 33%/64%/67% YoY resulting in EPS of PKR 8.12. We expect future earnings to follow the same trend as the Company is expected to benefit from deregulation, looking forward.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low